AC Immune SA
NASDAQ:ACIU
2.68 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | AC Immune SA |
Symbool | ACIU |
Munteenheid | USD |
Prijs | 2.68 |
Beurswaarde | 267,143,472 |
Dividendpercentage | 0% |
52-weken bereik | 2.25 - 4.978 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Andrea Pfeifer Ph.D. |
Website | https://www.acimmune.com |
An error occurred while fetching data.
Over AC Immune SA
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)